EP2485751
GLYX-13 til notkunar í aðferð við að meðhöndla erfiða geðdeyfð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
5.10.2010EP published:
21.5.2014EP application number:
10822514.5
EP translation filed:
14.8.2014Grant published:
15.9.2014EPO information:
European Patent Register
Max expiry date:
4.10.2030Expiry date:
4.10.2021
Title:
GLYX-13 for use in a method of treating refractory depression
Timeline
Today
5.10.2010EP application
21.5.2014EP Publication
14.8.2014Translation submitted
15.9.2014Registration published
4.10.2021Expires
Owner
Name:
Northwestern UniversityAddress:
633 Clark Street, 60208, Evanston, IL, US
Inventor
Name:
Moskal, Joseph.Address:
Evanston IL, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
248650 PDate:
5.10.2009Country:
US
Classification
Categories:
A61K 38/10, A61P 25/22, A61P 25/24
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.10.2014
Expires: 4.10.2015
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 1.10.2015
Expires: 4.10.2016
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 20.9.2016
Expires: 4.10.2017
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 19.9.2017
Expires: 4.10.2018
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.9.2018
Expires: 4.10.2019
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.9.2019
Expires: 4.10.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.9.2020
Expires: 4.10.2021
Payer: Sigurjónsson & Thor ehf.